Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
about
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) MelanomaSuperficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.Brazilian guidelines for diagnosis, treatment and follow-up of primary cutaneous melanoma - Part IIUse of 18F-fluorodeoxyglucose positron emission tomography in patients with rare head and neck cancersSuccessful treatment of triple primary tumor.Prediction of positron emission tomography/computed tomography (PET/CT) positivity in patients with high-risk primary melanoma.Comparison between F-Fluorodeoxyglucose Positron Emission Tomography and Sentinel Lymph Node Biopsy for Regional Lymph Nodal Staging in Patients with Melanoma: A Review of the Literature.No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma.Recent developments in the medical and surgical treatment of melanoma.FDG PET in early stage cutaneous malignant melanoma.Staging studies for cutaneous melanoma in the United States: a population-based analysis.Routine FDG PET-CT in patients with a high-risk localized melanoma has a high predictive positive value for nodal disease and high negative predictive value for the presence of distant metastases.Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.The role of preoperative positron emission tomography/computed tomography (PET/CT) in patients with high-risk melanoma.NeoplasmsMalignant melanoma
P2860
Q26770492-7841370A-98B0-41B2-8346-E44789BA7DE3Q34498776-3AF01D77-0A3D-4FCF-A487-A8B26E43AA3FQ35986399-AB084370-C782-40CA-B3F1-AAFFC3BC4D99Q36648843-6A6DA2AD-7D6F-4251-A23E-1BC0650530ABQ36663207-10332E86-7CC4-4D94-96B3-D2097433B59AQ37165629-74F604AC-67E5-4920-8301-4B03F452D1A1Q37303441-F54117AA-3C17-4D5A-BA3B-8A0E69BDA6F4Q37348344-B55701F5-7FA8-418A-A10A-B81C7A631FF1Q37975500-0FD7F899-7E66-4D8C-8F8E-FAFC5DF75C2AQ38129831-345DAA17-A0D6-465E-8A32-E4E1B54824D3Q38200004-0CAE1956-1DE9-4642-9EF0-664B24084C03Q38201174-3384F4AA-2C50-4712-8465-B82160B4A4ABQ53036857-D64BB947-6643-4524-A0FC-732B8B200E51Q53195557-84D22680-29BA-4D19-A0EE-73805E270556Q53243638-F2819471-8BBA-4EC4-A6B7-D5071DADDD0DQ54388993-BE1453C8-8882-4E17-A4A9-3163C70A6525Q56828372-C15D45D5-69EB-4DA5-A01C-25972EFA8341Q58690762-B757419D-694E-4E18-A800-7AC42F43CCCB
P2860
Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Futility of fluorodeoxyglucose ...... tients with T2 to T4 melanoma.
@ast
Futility of fluorodeoxyglucose ...... tients with T2 to T4 melanoma.
@en
type
label
Futility of fluorodeoxyglucose ...... tients with T2 to T4 melanoma.
@ast
Futility of fluorodeoxyglucose ...... tients with T2 to T4 melanoma.
@en
prefLabel
Futility of fluorodeoxyglucose ...... tients with T2 to T4 melanoma.
@ast
Futility of fluorodeoxyglucose ...... tients with T2 to T4 melanoma.
@en
P2093
P1433
P1476
Futility of fluorodeoxyglucose ...... tients with T2 to T4 melanoma.
@en
P2093
Edward A Levine
Jonathan Kraas
Paige B Clark
Perry Shen
Victoria Soo
P304
P356
10.1001/ARCHSURG.141.3.284
P577
2006-03-01T00:00:00Z